Cargando…
Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
Following the introduction of the molecular classification of gliomas by the WHO in 2016, molecularly-proven lineage conversion during glioma recurrence has never been reported. The reported two cases were initially diagnosed as oligodendroglioma with 1p/19q-codeletion and mutation of isocitrate deh...
Autores principales: | Kim, Jo-Heon, Jang, Woo-Youl, Jung, Tae-Young, Jung, Shin, Kim, Kyung-Keun, Kim, Hyung-Seok, Kim, Eun-Hee, Lee, Min-Cheol, Moon, Kyung-Sub, Lee, Kyung-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719522/ https://www.ncbi.nlm.nih.gov/pubmed/31508376 http://dx.doi.org/10.3389/fonc.2019.00828 |
Ejemplares similares
-
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas
por: Kim, Ju-Hwi, et al.
Publicado: (2017) -
Conventional and emerging treatments of astrocytomas and oligodendrogliomas
por: Kessler, Tobias, et al.
Publicado: (2022) -
Bevacizumab-refractory radiation necrosis with pathologic transformation of benign meningioma following adjuvant gamma knife radiosurgery: A rare case report
por: Kim, You-Sub, et al.
Publicado: (2020) -
The Clinical Characteristics of Subependymal Giant Cell Astrocytoma: Five Cases
por: Jung, Tae-Young, et al.
Publicado: (2015)